Testosterone cypionate

Generic Name
Testosterone cypionate
Brand Names
Depo-testosterone
Drug Type
Small Molecule
Chemical Formula
C27H40O3
CAS Number
58-20-8
Unique Ingredient Identifier
M0XW1UBI14
Background

Testosterone cypionate is a synthetic derivative of testosterone in the form of an oil-soluble 17 (beta)-cyclopentylpropionate ester. Its benefit compared to other testosterone derivatives is the slow rate of release after injection and longer half-life. It was developed by the company Pharmacia and Upjohn and FDA approved on July 25, 1979.

Indication

Testosterone cypionate is used in males that present conditions derived from a deficiency or absence of endogenous testosterone. These conditions are 1) primary hypogonadism, defined as the testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome or orchidectomy; and 2) hypogonadotropic hypogonadism characterized by id...

Associated Conditions
Hypergonadotropic Hypogonadism, Hypogonadotrophic Hypogonadism
Associated Therapies
-

CYP19A1 (Cytochrome P450 Family 19 Subfamily A Member 1) Gene and Pharmacogenetics of Response to Testosterone Therapy

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-06-22
Last Posted Date
2019-03-05
Lead Sponsor
VA Office of Research and Development
Target Recruit Count
105
Registration Number
NCT01378299
Locations
🇺🇸

Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States

🇺🇸

New Mexico VA Health Care System, Albuquerque, NM, Albuquerque, New Mexico, United States

The Effect of Testosterone Replacement on Bone Mineral Density in Boys and Men With Anorexia Nervosa

Phase 2
Withdrawn
Conditions
Interventions
First Posted Date
2009-03-02
Last Posted Date
2021-10-26
Lead Sponsor
Massachusetts General Hospital
Registration Number
NCT00853502
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath